The isothermal phase behavior of three gramicidin A'/phospholipid mixt
ures was investigated by an equilibrium Ca2+-binding technique. The ph
ospholipid component was 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS
), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS), or S/1-palm
itoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) at a constant mole r
atio of 1/4. The bulk aqueous free Ca2+ concentration, [Ca2+](f), in
equilibrium with one or two gramicidin A'/phospholipid fluid phases an
d a small amount of the Ca(phosphatidylserine)(2) gel phase, was measu
red as a function of composition at 20 degrees C by use of chromophori
c high-affinity Ca2+ chelators. The coexistence of two gramicidin A'/p
hospholipid fluid phases was detected by an invariance in [Ca2+](f) o
ver the range of compositions throughout which the two phases coexist.
The compositions of the two coexisting phases are determined by the c
ompositions at which the invariance in [Ca2+](f) begins and ends. Wit
h each of the gramicidin A'/phospholipid mixtures, we estimate that th
e composition of the gramicidin-poor phase is 0.03-0.04 mole fraction
gramicidin A' and the composition of the gramicidin-rich phase is 0.13
-0.14 mole fraction gramicidin A'. Characterization of these phases by
low-angle X-ray diffraction revealed that, in each case, the gramicid
in-poor phase is an L(alpha) phase and the gramicidin-rich phase is an
HII phase. The isothermal phase behavior of gramicidin A'/POPC mixtur
es at similar to 23 degrees C, as determined by low-angle X-ray diffra
ction, was found to be similar to that of the other gramicidin A'/phos
pholipid mixtures. P-31 nuclear magnetic resonance spectroscopy failed
to detect the gramicidin-rich H-II phase in all cases except when the
phospholipid component was DOPS. The general applicability of the equ
ilibrium Ca2+-binding technique to the detection of phospholipid phase
separations, including L(alpha)(1)/L(alpha)(2) phase separations, is
discussed.